MTNB Stock Analysis: Buy, Sell, or Hold?
MTNB - Matinas BioPharma Holdings, Inc.
$0.63
0.00 (0.43%)
▲
5d:
+1.74%
30d:
-17.28%
90d:
+15.2%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When MTNB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MTNB shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: MTNB shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: MTNB is currently trading at $0.63, which is considered oversold relative to its 30-day fair value range of $0.65 to $0.80.
Technical Outlook: Technically, MTNB is showing sideways momentum. The price is currently testing key support at $0.69. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+4634.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MTNB is showing sideways momentum. The price is currently testing key support at $0.69. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+4634.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.65 -
$0.80
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 4634.7% below Wall St target ($30.00)
Trading Range Analysis
30-Day Trading Range
$0.65 -
$0.80
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.69
Resistance Level
$0.88
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$30.00
(+4634.7%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 04, 2026 1:18 PM ET
Data refreshes hourly during market hours. Next update: 2:18 PM
Data refreshes hourly during market hours. Next update: 2:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MTNB showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 64 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 62 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 61 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 62 BUY |
